New research suggests that cancer survivors experiencing pain are more likely to use cannabis and cigarettes but less likely to consume alcohol than cancer survivors without pain.

Being obese at the time of MGUS diagnosis was associated with a 27% increase in the risk of progression to MM.

The FDA has granted fast track designation to amezalpat for the treatment of patients with hepatocellular carcinoma.

The NIH said this change will save billions of dollars. Universities said it will disrupt vital, life-saving research.

Pembrolizumab has robust, durable clinical benefit in patients with heavily pretreated CCGC and was tolerated in the overall population,” researchers wrote.

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

The Trump Administration’s censorship extends beyond federal websites and datasets to include research to be published in academic journals.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

Scientists are calling on the CDC to disclose data about the risks of bird flu that were posted briefly online last week but quickly deleted.

Provider prioritization of relationship-building alongside explanations could foster trust and facilitate open information exchange, supporting informed decisions,” researchers wrote.

Patients treated with platinum-based agents and taxanes had the highest prevalence of chronic painful chemotherapy-induced peripheral neuropathy, researchers found.